Marshall Wace, LLP Revolution Medicines, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,535,940 shares of RVMD stock, worth $59.6 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,535,940
Previous 1,208,929
27.05%
Holding current value
$59.6 Million
Previous $34.7 Million
42.78%
% of portfolio
0.08%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding RVMD
# of Institutions
219Shares Held
153MCall Options Held
321KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA14.8MShares$573 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.7MShares$571 Million0.09% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$478 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.55MShares$293 Million3.08% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.51MShares$291 Million1.13% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.4B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...